Novartis/Speedel’s Tekturna-Diuretic Combination Clears FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Fixed-dose blood pressure pill will reach market in early February, Novartis tells “The Pink Sheet” DAILY.
You may also be interested in...
Tekturna Combinations Targeted To Jumpstart Renin Inhibitor’s Sales
CEO Vasella maintains Tekturna has blockbuster potential; aliskiren combination with Diovan could be on the horizon.
Tekturna Combinations Targeted To Jumpstart Renin Inhibitor’s Sales
CEO Vasella maintains Tekturna has blockbuster potential; aliskiren combination with Diovan could be on the horizon.
Tekturna Shows Non-Inferiority To Merck’s Cozaar On Left Ventricular Hypertrophy
Combination of both medicines, however, did not achieve a statistically significant reduction in LVH over losartan alone.